The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|3|392-395

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.3, 2011-01, pp. : 392-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

By García-Donaire Jose Antonio   Segura Julian   Ruilope Luis Miguel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1587-1596

Informa Healthcare

Access to resources Recommend Favorite

Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy

By  

Current Medicinal Chemistry, Vol. 24, Iss. 28, 2017-09 ,pp. : 3104-3114

Bentham Science Publishers

Access to resources Recommend Favorite

The Renin-Angiotensin System and Advanced Glycation End-Products in Diabetic Retinopathy: Impacts and Synergies.

By  

Current Clinical Pharmacology, Vol. 8, Iss. 4, 2013-11 ,pp. : 285-296

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment and Prevention of Diabetic Nephropathy in Caucasian and Asian Patients: The Role of Renin-Angiotensin System Blockade

By Viberti Giancarlo  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 1, 2006-01 ,pp. : 49-55

Adis International

Access to resources Recommend Favorite

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy

By  

Current Pharmacogenomics, Vol. 2, Iss. 2, 2004-06 ,pp. : 157-162

Bentham Science Publishers

Access to resources Recommend Favorite